News Center

─  Specialized manufacturer  •  since 2005  ─

NEWS CENTER

Warming Blood to 37°C Before Exchange Transfusion: A Simple Step That Reduces Shivering and Hypothermia in Neonates

Author:

Origin:

Time of issue: 2026-10-14

Evidence from a randomized controlled study of 80 neonates undergoing peripheral arteriovenous synchronous exchange transfusion

Source: Shanghai Medical & Pharmaceutical Journal, 2017, Vol. 38, No. 19 · Neonatal Ward Clinical Study. This article is a summary and interpretation of the original literature for nursing communication and public education.

 

Key Data at a Glance

80 neonates enrolled; target warming temperature: 37°C

Shivering rate: 27.5% in the control group → 2.5% in the study group

Temperature decline rate: 30% in the control group → 0% in the study group

A randomized controlled study of 80 neonates undergoing peripheral arteriovenous synchronous exchange transfusion answers the question: Is a blood warmer worth using? The answer can be summarized in one sentence: It does not change the efficacy of exchange transfusion, but it significantly reduces shivering and hypothermia.

 

Introduction

When neonates with severe hyperbilirubinemia require exchange transfusion, the volume of blood transfused at one time is often 150–180 mL/kg. If blood is taken directly from cold storage or room temperature and infused, it may make an already thermolabile neonate 'colder and colder' during the exchange.

In this study, 80 neonates were randomly divided into two groups. One group received blood warmed to 37°C before infusion; the other received blood left at room temperature for 30 minutes before infusion. The study compared the efficacy of exchange transfusion and postoperative adverse reactions.

 

01 Why Is This Detail Worth Studying?

Exchange transfusion is an important method for rescuing severe hyperbilirubinemia and preventing bilirubin encephalopathy. The problem is that a large volume of blood is infused over a short period during exchange transfusion—approximately twice the neonate’s own blood volume.

Previous studies have suggested that massive infusion of blood that has not been adequately rewarmed can cause hypothermia during exchange transfusion and may even lead to cardiac dysfunction when blood rewarming is incomplete. At the same time, exchange transfusion can easily cause changes in serum ions closely related to cardiac electrical activity, such as calcium, potassium, and sodium.

Therefore, temperature management before blood enters the neonate’s body is not merely a question of “comfort.” It is a nursing detail that affects circulatory stability and procedural safety.

The question addressed by this study: Is warming exchange blood to 37°C with a blood warmer safer and more effective than the traditional practice of leaving it at room temperature for 30 minutes?

 

02 How Was the Study Designed?

Inclusion and Grouping

The study enrolled 80 neonates who met exchange transfusion indications in the neonatal ward from January 2014 to December 2016. All had hyperbilirubinemia meeting or exceeding the exchange transfusion criteria established by the Neonatology Group of the Chinese Pediatric Society, or had already shown signs of bilirubin encephalopathy.

There were 41 males and 39 females, with postnatal age 1–13 days and body weight 2.5–4.2 kg. They were divided by odd/even order of exchange transfusion into a control group and a study group, with 40 cases in each group. There were no significant differences in general baseline data between the two groups (P > 0.05).

Exchange Transfusion and Nursing Procedures

The neonates were placed on a far-infrared radiant warmer, in a supine position with appropriate fixation. ECG, oxygen saturation, blood pressure, respiration, and rectal temperature were monitored throughout the procedure.

Peripheral arteriovenous synchronous exchange transfusion was performed. Two venous lines were established:

One line for blood infusion;

Another line for continuous infusion of 5% calcium gluconate (1–2 mL per 100 mL of blood).

Blood was simultaneously withdrawn from the radial artery, brachial artery, or femoral artery.

The core difference between the groups was the temperature handling of the blood:

(1) Control group: Blood in the infusion line was left at room temperature for 30 minutes before use.

(2) Study group: Blood was warmed to 37°C using a blood transfusion warmer before use. The warmer had a temperature control accuracy of ±0.5°C, high-precision microcomputer control, a dry/wet heating structure, and maintained constant temperature regardless of season.

Observation Points

Rectal temperature, heart rate, respiration, blood pressure, and oxygen saturation were recorded at 5 minutes and 10 minutes after the start of exchange transfusion, then every 15 minutes, until 30 minutes after the end of exchange transfusion.

Adverse reactions such as shivering and temperature decline were also recorded. Preoperative and postoperative complete blood count, blood gas analysis, blood glucose, electrolytes, and serum bilirubin were compared.

 

03 Result 1: Does Warming Affect the Efficacy of Exchange Transfusion?

After exchange transfusion, total bilirubin, direct bilirubin, and indirect bilirubin decreased significantly in both groups—but there was no significant difference between the two groups (P > 0.05).

In other words, whether or not a blood warmer was used did not affect the bilirubin-removal effect of exchange transfusion.

Note: Data from Table 1 of the original article.

 

04 Result 2: What Improvements Did Warming Bring?

The differences appeared in adverse reactions.

In the study group, the incidence of shivering decreased from 27.5% in the control group to 2.5%. The incidence of temperature decline decreased from 30.0% to 0%. Both differences were statistically significant (P < 0.05 and P < 0.01).

Note: Data from Table 2 of the original article.

 

At the same time, after exchange transfusion, blood glucose and hemoglobin increased in both groups, while white blood cells and platelets decreased. There were no significant differences between the two groups in other electrolytes, blood gas analysis indicators, or pH (P > 0.05).

This indicates that warming does not disturb internal environment homeostasis and has good safety.

 

05 How Should These Results Be Understood?

Excess unconjugated bilirubin in peripheral blood can cross the blood-brain barrier, causing irreversible neurological damage in neonates, including seizures, visual and auditory impairment, and intellectual disability. Therefore, rapidly reducing serum bilirubin is the key to treatment.

The safety and efficacy of exchange transfusion have long been recognized. However, severe hyperbilirubinemia itself may be accompanied by respiratory depression, and the exchange transfusion process can also affect circulatory function, creating a risk of internal environment disturbance.

Limitations of Traditional Rewarming

The traditional method is to place blood in an incubator or a 35–37°C water bath for warming. This is often time-consuming, inaccurate, and may delay exchange transfusion, making safety difficult to guarantee.

Advantages of a Blood Warmer

A blood transfusion warmer transfers heat directly to flowing blood through the heated tubing circuit inside the device. It can continuously warm whole blood, blood products, medications, infusion fluids, or irrigation fluids from cold storage or room temperature to the set temperature—quickly and accurately.

The study noted that warming blood or fluid products to 36–37°C is safe and comfortable and has no effect on blood components.

This is especially critical for neonates: their bodies are not fully developed, their tolerance to procedures is poor, and their ability to self-regulate temperature is weaker. They are therefore more prone to shivering and temperature decline during exchange transfusion. A blood warmer can raise the temperature of the infused blood to some extent, thereby reducing the risk of hypothermia during exchange transfusion—this is precisely the value found in this study.

 

06 Implications for Clinical Nursing

Turning what “looks like just warming the blood a little” into a standard procedure reduced shivering from 27.5% to 2.5% and temperature decline from 30% to 0%.

The following are actionable nursing points:

(1) Put temperature management first: Make warming blood to 37°C a standard step before exchange transfusion, replacing the practice of “leaving it at room temperature for 30 minutes.”

(2) Fix monitoring time points: Record at 5 and 10 minutes after the start of exchange transfusion, then every 15 minutes, until 30 minutes after the end. Focus on rectal temperature.

Watch for warning signs: If body temperature drops rapidly and ECG disturbances appear, stop transfusion immediately and inform the physician.

(3) Give calcium supplementation simultaneously to prevent hypocalcemia: Continuously infuse 5% calcium gluconate through each input line at approximately 1–2 mL per 100 mL of blood.

(4) Maintain basic monitoring throughout: Radiant warmer for warmth, supine position with fixation, and continuous monitoring of ECG, oxygen saturation, blood pressure, respiration, and rectal temperature.

 

Conclusion

Using a blood transfusion warmer to warm blood during peripheral arteriovenous synchronous exchange transfusion in neonates does not change the bilirubin-removal efficacy of exchange transfusion. However, it significantly reduces postoperative hypothermia, shivering, and other complications, thereby improving the safety and comfort of the exchange transfusion process.

This nursing improvement—with efficacy as the foundation and safety as the added value—deserves to be incorporated into routine neonatal exchange transfusion care.

 

References:

1. Chen Bing. Application of a blood transfusion warmer in nursing care for 40 neonates undergoing peripheral arteriovenous synchronous exchange transfusion [J]. Shanghai Medical & Pharmaceutical Journal, 2017, 38(19): 49–53.

2. Ye Yongqing, Liang Ni, Huang Liyun, et al. Monitoring and nursing care of peripheral arteriovenous synchronous exchange transfusion for neonatal hyperbilirubinemia [J]. Guangdong Medical Journal, 2011, 32(1): 131–133.

3. Yang Yi. Nursing care of peripheral arteriovenous synchronous exchange transfusion for neonatal hyperbilirubinemia [J]. China Practical Medicine, 2013, 8(1): 183–184.

4. Pei Yufang, Zhang Lianjun, Zhang Hong, et al. Observation and nursing care of peripheral arteriovenous synchronous exchange transfusion for severe neonatal hyperbilirubinemia [J]. China Practical Medicine, 2013, 8(25): 185–186.

5. Wang Yuan, Chen Qiong. Nursing care of 110 neonates undergoing peripheral arteriovenous synchronous exchange transfusion [J]. West China Medical Journal, 2016, 31(11): 1890–1892.

6. Huang Qian, Wang Honggeng, Fan Chunmei, et al. Application effect of a blood transfusion warmer during infusion of stored red blood cell suspension [J]. Journal of Clinical Anesthesiology, 2015, 31(10): 973–975.

Source Statement

This article is a summary and interpretation based on Chen Bing’s article “Application of a blood transfusion warmer in nursing care for 40 neonates undergoing peripheral arteriovenous synchronous exchange transfusion,” published in Shanghai Medical & Pharmaceutical Journal, 2017, Vol. 38, No. 19. The original text has not been copied or reproduced. The data and conclusions remain faithful to the original literature.

Copyright Notice

This article is secondary public education/nursing communication content based on publicly available medical literature, with the original source cited. If the original authors or the journal have any objections, please contact us for removal.

Medical knowledge popularization · Nursing experience exchange

This content does not constitute medical advice. For specific diagnosis, treatment, and nursing care, please follow professional medical instructions.